Jared Hendricks - Amer Renal Independent Director
Director
Mr. Jared S. Hendricks is an Independent Director of the company. Mr. Hendricks also serves on the boards of directors of IPC Corporationration and Ligado Networks LLC. Mr. Hendricks joined Centerbridge Partners, L.P. in 2006 and is currently a Senior Managing Director. Prior to joining Centerbridge, from 2004 to 2006, Mr. Hendricks was an Associate at Silver Lake Partners, a private equity firm focused on investments in technology and related growth companies. Prior to joining Silver Lake, he was an investment banking analyst within the Global Industrial and Services group at Credit Suisse First Boston since 2010.
| Age | 38 |
| Tenure | 14 years |
| Phone | 978 922-3080 |
| Web | www.americanrenal.com |
Amer Renal Management Efficiency
The company has Return on Asset of 4.35 % which means that on every $100 spent on assets, it made $4.35 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 17.51 %, implying that it generated $17.51 on every 100 dollars invested. Amer Renal's management efficiency ratios could be used to measure how well Amer Renal manages its routine affairs as well as how well it operates its assets and liabilities.Amer Renal Assoc has 724.51 M in debt with debt to equity (D/E) ratio of 3.94, meaning that the company heavily relies on borrowing funds for operations. Amer Renal Assoc has a current ratio of 1.03, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Amer to invest in growth at high rates of return.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Matthew Paull | Air Products and | 69 | |
| Deborah Kissire | Axalta Coating Systems | 63 | |
| Robert Mclaughlin | Axalta Coating Systems | 63 | |
| Yoad Hayash | Supercom | N/A | |
| Elizabeth Lempres | Axalta Coating Systems | 60 | |
| Arie Trabelsi | Supercom | 66 | |
| Chadwick Deaton | Air Products and | 68 | |
| Samuel Smolik | Axalta Coating Systems | 67 | |
| Steven Chapman | Axalta Coating Systems | 66 | |
| John Harper | NL Industries | 59 | |
| HingYuen Ho | Air Products and | 61 | |
| Michael Binney | Emerson Radio | 65 | |
| Rakesh Sachdev | Axalta Coating Systems | 68 | |
| Susan Carter | Air Products and | 61 | |
| Cecil Moore | NL Industries | 81 | |
| Carrie McKim | Codexis | N/A | |
| Meredith Mendes | NL Industries | 62 | |
| Margaret McGlynn | Air Products and | 59 | |
| Kareem Sethi | Emerson Radio | 41 | |
| Edward Monser | Air Products and | 70 | |
| Kin Yuen | Emerson Radio | 64 | |
Management Performance
| Return On Equity | 17.51 | |||
| Return On Asset | 4.35 |
Amer Renal Assoc Leadership Team
Elected by the shareholders, the Amer Renal's board of directors comprises two types of representatives: Amer Renal inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amer. The board's role is to monitor Amer Renal's management team and ensure that shareholders' interests are well served. Amer Renal's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amer Renal's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Syed Kamal, President, Co-Founder, Director | ||
| Thomas Erickson, Independent Director | ||
| Jared Hendricks, Independent Director | ||
| John Jureller, Independent Director | ||
| Robert Fish, Independent Director | ||
| Joseph Carlucci, Chairman of the Board, Chief Executive Officer, Co-Founder | ||
| Michael Boxer, Independent Director | ||
| Jeremy Gelber, Independent Director | ||
| Susanne Clark, Independent Director | ||
| Don Williamson, Chief Operating Officer, Executive Vice President | ||
| Christopher Hocevar, Independent Director | ||
| Mark Herbers, Interim Chief Financial Officer, Interim Chief Accounting Officer |
Amer Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amer Renal a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 17.51 | |||
| Return On Asset | 4.35 | |||
| Profit Margin | (1.11) % | |||
| Operating Margin | 9.73 % | |||
| Current Valuation | 1.26 B | |||
| Shares Outstanding | 34.54 M | |||
| Shares Owned By Insiders | 9.15 % | |||
| Shares Owned By Institutions | 80.77 % | |||
| Number Of Shares Shorted | 608.63 K | |||
| Price To Earning | 144.04 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Amer Stock
If you are still planning to invest in Amer Renal Assoc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Renal's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |